Humana Inc. (NYSE:HUM) Shares Purchased by Capital Advisors Ltd. LLC

Capital Advisors Ltd. LLC grew its holdings in Humana Inc. (NYSE:HUM) by 17.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 213 shares of the insurance provider’s stock after purchasing an additional 31 shares during the quarter. Capital Advisors Ltd. LLC’s holdings in Humana were worth $80,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the stock. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares during the last quarter. Private Wealth Management Group LLC acquired a new stake in shares of Humana in the fourth quarter valued at about $32,000. Family Firm Inc. acquired a new position in Humana during the 2nd quarter worth approximately $37,000. Riverview Trust Co acquired a new stake in Humana in the second quarter valued at approximately $44,000. Finally, Carolinas Wealth Consulting LLC grew its position in Humana by 274.1% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after acquiring an additional 74 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Bank of America upped their price target on Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research report on Monday, May 20th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Monday, August 19th. Piper Sandler assumed coverage on shares of Humana in a research report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price objective for the company. Deutsche Bank Aktiengesellschaft raised their price target on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Robert W. Baird initiated coverage on Humana in a report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target on the stock. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, Humana has a consensus rating of “Hold” and an average price target of $396.35.

Humana Price Performance

Shares of HUM opened at $352.90 on Monday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.67. The company has a market capitalization of $42.52 billion, a price-to-earnings ratio of 21.97, a P/E/G ratio of 2.09 and a beta of 0.51. The business’s 50-day moving average is $367.72 and its 200-day moving average is $346.43. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company had revenue of $29.54 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter last year, the business posted $8.94 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities research analysts expect that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.00%. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.